
Forvia car cockpit (source: Forvia)
Shortly after Stellantis announced that it was discontinuing the development of its hydrogen fuel cell technology via Symbio, in which Forvia is a co-shareholder, the latter posted strong mid-year results.
Strict cost and cash discipline driving improvement
o Organic growth of 1.1%, driven by Electronics and Seating.
o Operating margin up 20bps, supported by strict cost control, well-contained impact of US tariffs and the first benefits of the EU-FORWARD program.
o Net Cash Flow more than doubled vs H1 2024, driven by recurring elements: EBITDA increased by €127m and Capex and Capitalized R&D reduced by €232m.
o Net result penalized by non-cash financial assets depreciation related to SYMBIO.

Organisational transformation to promote further accountability and operational excellence
o Design of a new division centric organization with clear lines of P&L responsibility to drive business performance.
o Launch of Simplify project to streamline organization and reduce indirect and structural costs; €110m cost base reduction target by 2028, backed by c.€150m restructuring costs over 2025–2028.
Confirmed full-year 2025 guidance
o Sales, operating margin, net cash flow, and leverage targets reiterated.
Martin FISCHER, Chief Executive Officer of FORVIA, declared:
“Our three key priorities — delivering performance, driving business transformation and invigorating our culture— shape our decisions and actions.
The quality of our first-half results demonstrates the remarkable commitment of our teams and our strong focus on these priorities. This performance, together with the rising outcomes of self-help measures and the continued strict cost and cash control, enables us to confirm our full-year guidance in a challenging and volatile environment. It also further supports our primary objective of debt reduction.
In the first half, we launched major initiatives that underpin our strategic shift.
We are streamlining our operating model into a division-centric structure that enhances agility, accelerates decision-making and fosters accountability. Meanwhile, the SIMPLIFY project is building a leaner organization, generating additional cost savings.
At the same time, we are transforming our business portfolio through a thorough strategic review of each business group and all product lines, while actively pursuing asset disposals.
We will present our strategy and mid-term financial goals at our Capital Market Day on February 24, 2026.”
Despite the Symbio/Stellantis situation, these strong results have boosted confidence in the financial markets. Forvia’s share price rose by 13,43% yesterday, 28 July 2025, closing at 11,655 € ($US13.44) at the end of the day.